Teva Pharmaceutical Industries (TEVA) Revenue Growth (3y) (2012 - 2026)
Teva Pharmaceutical Industries (TEVA) Revenue Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 2.22% |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | 4.22% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -0.31% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 9.51% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.40% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 28.43% |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 8.98% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | -7.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.22% |
| Mar 31, 2026 | 2.84% |
| Dec 31, 2025 | 6.65% |
| Sep 30, 2025 | 7.61% |
| Jun 30, 2025 | 3.32% |
| Mar 31, 2025 | 2.05% |
| Dec 31, 2024 | -10.90% |
| Sep 30, 2024 | 3.68% |
| Jun 30, 2024 | 2.12% |
| Mar 31, 2024 | -1.38% |
| Dec 31, 2023 | 0.02% |
| Sep 30, 2023 | -1.08% |
| Jun 30, 2023 | 0.07% |
| Mar 31, 2023 | -5.64% |
| Dec 31, 2022 | -4.56% |
| Sep 30, 2022 | -4.23% |
| Jun 30, 2022 | -3.22% |
| Mar 31, 2022 | -4.09% |
| Dec 31, 2021 | -2.47% |
| Sep 30, 2021 | -3.94% |